Wyeth 1105
Laufzeit: 01.01.2011 - 31.12.2015
imported
Kurzfassung
An open-label, phase I study of R-CVP or R-GDP in combination with Inotuzumab Ozogamicin in subjects with CD20 positive NHL
Laufzeit: 01.01.2011 - 31.12.2015
An open-label, phase I study of R-CVP or R-GDP in combination with Inotuzumab Ozogamicin in subjects with CD20 positive NHL
